Profile
Louise Armstrong-Denby is an Independent Director at CellaVision AB since 2023.
Prior to this, she was the Global Sales Director at Andor Technology Ltd. and the Chief Commercial Officer at Visiopharm A from 2019 to 2023.
She also served as the Chief Sales Officer at Random42 Ltd.
Louise Armstrong-Denby active positions
| Companies | Position | Start |
|---|---|---|
| CELLAVISION AB | Director/Board Member | 31/12/2022 |
Former positions of Louise Armstrong-Denby
| Companies | Position | End |
|---|---|---|
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Corporate Officer/Principal | 31/12/2022 |
| ANDOR TECHNOLOGY PLC | Sales & Marketing | - |
Random42 Ltd.
Random42 Ltd. Movies/EntertainmentConsumer Services Provides digital solutions to pharmaceutical and biotech sectors | Sales & Marketing | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
CellaVision AB
CellaVision AB Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
Andor Technology Ltd.
Andor Technology Ltd. Computer PeripheralsElectronic Technology Develops and manufactures digital cameras and glasses | Electronic Technology |
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Technology Services |
Random42 Ltd.
Random42 Ltd. Movies/EntertainmentConsumer Services Provides digital solutions to pharmaceutical and biotech sectors | Consumer Services |
- Stock Market
- Insiders
- Louise Armstrong-Denby
















